article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Setting or Dataset Five electronic systems of community clinic. Outcome Measures Changes of China-PAR score and cardiovascular hospitalization events.

article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? Cardiovascular Events The SELECT trial 1 randomized 17,604 patients with preexisting CVD and overweight/obesity. Patients with CKD experience less CKD-related events (24% less).

Diabetes 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ocular Toxicities of Targeted Cancer Therapies

Physician's Weekly

The following is a summary of “Clinical and imaging strategies for the assessment of the ocular side effects of systemic targeted anti-cancer therapies,” published in the April 2025 issue of the European Journal of Cancer by Michaels et al.

article thumbnail

Why Identifying and Managing Giant Cell Arteritis as an Emergency Is Crucial

Physician's Weekly

I’m the Vice Chairman of Rheumatology at the Cleveland Clinic and the co-director of the Center for Vasculitis Care and Research. And I’m here today to talk about giant cell arteritis in clinical practice. So always important to consider the clinical context and patient symptoms there. Hello everyone.

article thumbnail

Supporting Healthy Aging With Tailored Obesity Management Strategies

Physician's Weekly

Chae : The four pillars of obesity care is a helpful framework that defines the essential elements of obesity care, which include nutrition therapy, physical activity, behavioral modification, and, if clinically indicated, medical interventions (eg, medication management, bariatric procedures, and complication management).

article thumbnail

Updates in ID and Nephrology: Lona Mody, Rasheeda Hall, Devika Nair, Sonali Advani

GeriPal

We have a discussion about the decision to remove race, a social construct, from clinical risk calculators (though I’m not 100% sold that race should always be removed – if removal is likely to worsen disparities for example – at least until a superior race-blind calculator can be developed). difficile infections.

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

Join us as we dive deeper into these studies and discuss the implications for clinical practice and patient care. And there’s so much work on, you know, you’ve got to take these medicines, you got to prevent this treat, that there isn’t that same sort of clinical momentum towards deprescribing. Ethical and practical.